Literature DB >> 28855314

IL-1β and IL-23 Promote Extrathymic Commitment of CD27+CD122- γδ T Cells to γδT17 Cells.

Andreas Muschaweckh1, Franziska Petermann1, Thomas Korn2,3.   

Abstract

γδT17 cells are a subset of γδ T cells committed to IL-17 production and are characterized by the expression of IL-23R and CCR6 and lack of CD27 expression. γδT17 cells are believed to arise within a narrow time window during prenatal thymic development. In agreement with this concept, we show in this study that adult Rag1-/- recipient mice of Il23rgfp/+ (IL-23R reporter) bone marrow selectively lack IL-23R+ γδT17 cells. Despite their absence in secondary lymphoid tissues during homeostasis, γδT17 cells emerge in bone marrow chimeric mice upon induction of skin inflammation by topical treatment with imiquimod cream (Aldara). We demonstrate that IL-1β and IL-23 together are able to promote the development of bona fide γδT17 cells from peripheral CD122-IL-23R- γδ T cells, whereas CD122+ γδ T cells fail to convert into γδT17 cells and remain stable IFN-γ producers (γδT1 cells). IL-23 is instrumental in expanding extrathymically generated γδT17 cells. In particular, TCR-Vγ4+ chain-expressing CD122-IL-23R- γδ T cells are induced to express IL-23R and IL-17 outside the thymus during skin inflammation. In contrast, TCR-Vγ1+ γδ T cells largely resist this process because prior TCR engagement in the thymus has initiated their commitment to the γδT1 lineage. In summary, our data reveal that the peripheral pool of γδ T cells retains a considerable degree of plasticity because it harbors "naive" precursors, which can be induced to produce IL-17 and replenish peripheral niches that are usually occupied by thymus-derived γδT17 cells.
Copyright © 2017 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28855314      PMCID: PMC5632841          DOI: 10.4049/jimmunol.1700287

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  50 in total

1.  Cutting edge: an IL-17F-CreEYFP reporter mouse allows fate mapping of Th17 cells.

Authors:  Andrew L Croxford; Florian C Kurschus; Ari Waisman
Journal:  J Immunol       Date:  2009-02-01       Impact factor: 5.422

2.  The transcription factor T-bet is induced by IL-15 and thymic agonist selection and controls CD8αα(+) intraepithelial lymphocyte development.

Authors:  Christoph S N Klose; Katharina Blatz; Yannick d'Hargues; Pedro P Hernandez; Michael Kofoed-Nielsen; Juliane F Ripka; Karolina Ebert; Sebastian J Arnold; Andreas Diefenbach; Ed Palmer; Yakup Tanriver
Journal:  Immunity       Date:  2014-08-21       Impact factor: 31.745

Review 3.  Development and function of interleukin 17-producing γδ T cells.

Authors:  Thomas Korn; Franziska Petermann
Journal:  Ann N Y Acad Sci       Date:  2012-01-12       Impact factor: 5.691

4.  Thymic selection determines gammadelta T cell effector fate: antigen-naive cells make interleukin-17 and antigen-experienced cells make interferon gamma.

Authors:  Kirk D C Jensen; Xiaoqin Su; Sunny Shin; Luke Li; Sawsan Youssef; Sho Yamasaki; Lawrence Steinman; Takashi Saito; Richard M Locksley; Mark M Davis; Nicole Baumgarth; Yueh-hsiu Chien
Journal:  Immunity       Date:  2008-06-26       Impact factor: 31.745

5.  Unlike αβ T cells, γδ T cells, LTi cells and NKT cells do not require IRF4 for the production of IL-17A and IL-22.

Authors:  Hartmann Raifer; Azita J Mahiny; Nadine Bollig; Franziska Petermann; Anne Hellhund; Kerstin Kellner; Anna Guralnik; Katharina Reinhard; Evita Bothur; Magdalena Huber; Stefan Bauer; Max Löhning; Elina A Kiss; Stephanie C Ganal; Andreas Diefenbach; Thomas Korn; Michael Lohoff
Journal:  Eur J Immunol       Date:  2012-10-17       Impact factor: 5.532

6.  γδ T cells recognize a microbial encoded B cell antigen to initiate a rapid antigen-specific interleukin-17 response.

Authors:  Xun Zeng; Yu-Ling Wei; Jun Huang; Evan W Newell; Hongxiang Yu; Brian A Kidd; Michael S Kuhns; Ray W Waters; Mark M Davis; Casey T Weaver; Yueh-hsiu Chien
Journal:  Immunity       Date:  2012-09-06       Impact factor: 31.745

7.  Gamma/delta T cells are the predominant source of interleukin-17 in affected joints in collagen-induced arthritis, but not in rheumatoid arthritis.

Authors:  Yoshinaga Ito; Takashi Usui; Shio Kobayashi; Mikiko Iguchi-Hashimoto; Hiromu Ito; Hiroyuki Yoshitomi; Takashi Nakamura; Masakazu Shimizu; Daisuke Kawabata; Naoichiro Yukawa; Motomu Hashimoto; Noriko Sakaguchi; Shimon Sakaguchi; Hajime Yoshifuji; Takaki Nojima; Koichiro Ohmura; Takao Fujii; Tsuneyo Mimori
Journal:  Arthritis Rheum       Date:  2009-08

8.  Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity.

Authors:  Caroline E Sutton; Stephen J Lalor; Cheryl M Sweeney; Corinna F Brereton; Ed C Lavelle; Kingston H G Mills
Journal:  Immunity       Date:  2009-08-13       Impact factor: 31.745

9.  T cell receptor signal strength in Treg and iNKT cell development demonstrated by a novel fluorescent reporter mouse.

Authors:  Amy E Moran; Keli L Holzapfel; Yan Xing; Nicole R Cunningham; Jonathan S Maltzman; Jennifer Punt; Kristin A Hogquist
Journal:  J Exp Med       Date:  2011-05-23       Impact factor: 14.307

10.  TCR signal strength controls thymic differentiation of discrete proinflammatory γδ T cell subsets.

Authors:  Edgar Fernández-Malavé; Bruno Silva-Santos; Miguel Muñoz-Ruiz; Julie C Ribot; Ana R Grosso; Natacha Gonçalves-Sousa; Ana Pamplona; Daniel J Pennington; José R Regueiro
Journal:  Nat Immunol       Date:  2016-04-04       Impact factor: 25.606

View more
  16 in total

Review 1.  γδTCR-independent origin of neonatal γδ T cells prewired for IL-17 production.

Authors:  Nicholas A Spidale; Michela Frascoli; Joonsoo Kang
Journal:  Curr Opin Immunol       Date:  2019-05-23       Impact factor: 7.486

Review 2.  Targeting Cytokine Signals to Enhance γδT Cell-Based Cancer Immunotherapy.

Authors:  Yuan Song; Yonghao Liu; Huey Yee Teo; Haiyan Liu
Journal:  Front Immunol       Date:  2022-06-07       Impact factor: 8.786

Review 3.  γδ T Cells in Brain Homeostasis and Diseases.

Authors:  Jang Hyun Park; In Kang; Heung Kyu Lee
Journal:  Front Immunol       Date:  2022-05-26       Impact factor: 8.786

Review 4.  The Emerging Complexity of γδT17 Cells.

Authors:  Duncan R McKenzie; Iain Comerford; Bruno Silva-Santos; Shaun R McColl
Journal:  Front Immunol       Date:  2018-04-20       Impact factor: 7.561

Review 5.  Tissue Adaptations of Memory and Tissue-Resident Gamma Delta T Cells.

Authors:  Camille Khairallah; Timothy H Chu; Brian S Sheridan
Journal:  Front Immunol       Date:  2018-11-27       Impact factor: 7.561

6.  IL-7-dependent compositional changes within the γδ T cell pool in lymph nodes during ageing lead to an unbalanced anti-tumour response.

Authors:  Hung-Chang Chen; Nils Eling; Celia Pilar Martinez-Jimenez; Louise McNeill O'Brien; Valentina Carbonaro; John C Marioni; Duncan T Odom; Maike de la Roche
Journal:  EMBO Rep       Date:  2019-07-08       Impact factor: 8.807

7.  Differential Roles of the mTOR-STAT3 Signaling in Dermal γδ T Cell Effector Function in Skin Inflammation.

Authors:  Yihua Cai; Feng Xue; Hui Qin; Xu Chen; Na Liu; Chris Fleming; Xiaoling Hu; Huang-Ge Zhang; Fuxiang Chen; Jie Zheng; Jun Yan
Journal:  Cell Rep       Date:  2019-06-04       Impact factor: 9.423

8.  Ability of γδ T cells to modulate the Foxp3 T cell response is dependent on adenosine.

Authors:  Dongchun Liang; Jeong-Im Woo; Hui Shao; Willi K Born; Rebecca L O'Brien; Henry J Kaplan; Deming Sun
Journal:  PLoS One       Date:  2018-05-17       Impact factor: 3.240

Review 9.  Thymic Program Directing the Functional Development of γδT17 Cells.

Authors:  Youenn Jouan; Emmanuel C Patin; Maya Hassane; Mustapha Si-Tahar; Thomas Baranek; Christophe Paget
Journal:  Front Immunol       Date:  2018-05-08       Impact factor: 7.561

10.  Genetic models reveal origin, persistence and non-redundant functions of IL-17-producing γδ T cells.

Authors:  Inga Sandrock; Annika Reinhardt; Sarina Ravens; Christoph Binz; Anneke Wilharm; Joana Martins; Linda Oberdörfer; Likai Tan; Stefan Lienenklaus; Baojun Zhang; Ronald Naumann; Yuan Zhuang; Andreas Krueger; Reinhold Förster; Immo Prinz
Journal:  J Exp Med       Date:  2018-11-19       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.